Skip to main content

The company is pleased to announce that following further developments in the MEDEVAC program and the consequent rise in values accordingly, SBS GROUP LTD has approached the company to increase its stake significantly with a further transaction on amended
specified terms.

We can confirm that those are the issuance of 45,000,000 new shares @ USD $ 2.50 in exchange for 20,812,000 SBS GROUP LTD new Common Shares @£4.00 per share.

Both share holdings are unrestricted and rank pari passu with the respective existing Capital of each Company . Bearer format has been accepted as the delivery mechanism for this transaction
The Board are very excited to further align the company with a powerful Investor partner with an impressive strong balance sheet. We are looking into a significant Capital raise to expand the working relationship with dedicated Industry partners and their global participants.

A further detailed statement will be following within 30 days on this progressive developing strategy.